Hubro Therapeutics

Bactheravax

This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.

Nykode Therapeutics

This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.

Geneos Therapeutics

This company develops personalised DNA-based therapeutic cancer vaccines and immunotherapies for patients with advanced hepatocellular carcinoma and other solid tumours.

Neobe

The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.

Haptena Therapeutics

This biotechnology company develops immunotherapies for patients with oncogene-driven cancers by integrating precision oncology with immune engineering.

Revealis Biotherapeutics

This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.

IO Biotech

The company develops immune-modulating therapeutic cancer vaccines to treat patients with melanoma and other solid tumours.

Medici Therapeutics

The company develops personalised mRNA cancer vaccines and T cell therapies for patients to treat tumours and combat age-related cellular decline.